Cargando…

Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer

Detalles Bibliográficos
Autores principales:	Liang, Naixin, Bing, Zhongxing, Wang, Yadong, Liu, Xinyu, Guo, Chao, Cao, Lei, Xu, Yuan, Song, Yang, Gao, Chao, Tian, Zhenhuan, Wu, Pancheng, Xue, Jianchao, Li, Bowen, Jia, Ziqi, Yang, Xiaoying, Wu, Yijun, Yu, Ruoying, Liu, Rui, Chen, Xiaoxi, Ou, Qiuxiang, Bao, Hua, Wu, Xue, Cao, Zhili, Li, Ji, Li, Shanqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091990/ https://www.ncbi.nlm.nih.gov/pubmed/35538869 http://dx.doi.org/10.1002/ctm2.847

Ejemplares similares

Pathological complete response to neoadjuvant ceritinib of a crizotinib‐resistant, stage IIIB non‐small cell lung cancer with ALK rearrangement: A case report
por: Bing, Zhongxing, et al.
Publicado: (2021)

Characteristics of T-Cell Receptor Repertoire and Correlation With EGFR Mutations in All Stages of Lung Cancer
por: Yang, Huaxia, et al.
Publicado: (2021)

DNA methylation patterns at and beyond the histological margin of early-stage invasive lung adenocarcinoma radiologically manifested as pure ground-glass opacity
por: Jia, Ziqi, et al.
Publicado: (2021)

Comprehensive genomic profiling aids in understanding the lesion origins of a patient with six synchronous invasive lung adenocarcinomas: a case study
por: Song, Yang, et al.
Publicado: (2020)

Fatal Tumour Lysis Syndrome Induced by Brigatinib in a Lung Adenocarcinoma Patient Treated With Sequential ALK Inhibitors: A Case Report
por: Wang, Yadong, et al.
Publicado: (2021)

Expression and prognostic analyses of ITGA11, ITGB4 and ITGB8 in human non-small cell lung cancer
por: Wu, Pancheng, et al.
Publicado: (2019)

Comprehensive analysis of T cell receptor repertoire in patients with KRAS mutant non-small cell lung cancer
por: Wang, Yadong, et al.
Publicado: (2022)

Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced EGFR-Mutated, Non-Small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-Analysis
por: Xue, Jianchao, et al.
Publicado: (2022)

Detection of Potential Mutated Genes Associated with Common Immunotherapy Biomarkers in Non-Small-Cell Lung Cancer Patients
por: Cao, Lei, et al.
Publicado: (2022)

Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation
por: Song, Yang, et al.
Publicado: (2023)

Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
por: Wu, Pancheng, et al.
Publicado: (2020)

Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q
por: Song, Yang, et al.
Publicado: (2020)

Vesicular formation regulated by ERK/MAPK pathway mediates human erythroblast enucleation
por: An, Chao, et al.
Publicado: (2021)

First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up
por: Jia, Ziqi, et al.
Publicado: (2020)

Machine Learning-Assisted Dual-Marker Detection in Serum Small Extracellular Vesicles for the Diagnosis and Prognosis Prediction of Non-Small Cell Lung Cancer
por: Li, Wenzhe, et al.
Publicado: (2022)

Survival and prognostic factors of lung cancer patients with preexisting connective tissue disease: a retrospective cohort study
por: Yang, Huaxia, et al.
Publicado: (2020)

肺微小脑膜上皮样结节——认知进展与争论
por: LI, Haochen, et al.
Publicado: (2023)

Efficient isolation and quantification of circulating tumor cells in non-small cell lung cancer patients using peptide-functionalized magnetic nanoparticles
por: Liang, Naixin, et al.
Publicado: (2020)

Long noncoding RNA MALAT-1 is a novel inflammatory regulator in human systemic lupus erythematosus
por: Yang, Huaxia, et al.
Publicado: (2017)

Clinical utility of cerebrospinal fluid-derived circular RNAs in lung adenocarcinoma patients with brain metastases
por: Wang, Zhen, et al.
Publicado: (2022)

KLF8 overexpression promotes the growth of human lung cancer cells by promoting the expression of JMJD2A
por: Ma, Dongjie, et al.
Publicado: (2019)

Clinical and molecular characteristics of Chinese non‐small cell lung cancer patients with ERBB2 transmembrane domain mutations
por: Fan, Yun, et al.
Publicado: (2020)

Clinical and molecular characteristics of kinase domain duplications across diverse cancer types in the Chinese population
por: Lai, Xiaojing, et al.
Publicado: (2022)

HER2 transmembrane domain mutation: comprehensive characteristics and real-world evidence of treatment response in Chinese lung adenocarcinoma
por: Jia, Ziqi, et al.
Publicado: (2021)

Clinicopathological models for predicting lymph node metastasis in patients with early-stage lung adenocarcinoma: the application of machine learning algorithms
por: Chong, Yuming, et al.
Publicado: (2021)

Ginsenoside-Rd Promotes Neurite Outgrowth of PC12 Cells through MAPK/ERK- and PI3K/AKT-Dependent Pathways
por: Wu, Song-Di, et al.
Publicado: (2016)

Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution
por: Li, Kaidi, et al.
Publicado: (2017)

Preoperative Prediction of Lymph Node Metastasis in Patients With Early-T-Stage Non-small Cell Lung Cancer by Machine Learning Algorithms
por: Wu, Yijun, et al.
Publicado: (2020)

Robo2 and Gen1 Coregulate Ureteric Budding by Activating the MAPK/ERK Signaling Pathway in Mice
por: Li, Yaxin, et al.
Publicado: (2022)

USP5 knockdown alleviates lung cancer progression via activating PARP1-mediated mTOR signaling pathway
por: Cao, Lei, et al.
Publicado: (2023)

An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Comprehensive genomic profiling of colorectal cancer patients reveals differences in mutational landscapes among clinical and pathological subgroups
por: Li, Peng, et al.
Publicado: (2022)

MAPK-ERK Pathway
por: Park, Jong-In
Publicado: (2023)

Temozolomide encapsulated and folic acid decorated chitosan nanoparticles for lung tumor targeting: improving therapeutic efficacy both in vitro and in vivo
por: Li, Kaidi, et al.
Publicado: (2017)

Metastatic Patterns of Mediastinal Lymph Nodes in Small-Size Non-small Cell Lung Cancer (T1b)
por: Wu, Yijun, et al.
Publicado: (2020)

Pan‐cancer molecular analysis of EGFR large fragment deletion in the Asian population
por: Pu, Jun, et al.
Publicado: (2023)

The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway
por: Guo, Feng, et al.
Publicado: (2018)

Altered Signaling Pathways Revealed by Comprehensive Genomic Profiling in Patients With Unknown Primary Tumors
por: Yang, Zhen, et al.
Publicado: (2022)

Layer specific and general requirements for ERK/MAPK signaling in the developing neocortex
por: Xing, Lei, et al.
Publicado: (2016)

Leptin regulates disc cartilage endplate degeneration and ossification through activation of the MAPK‐ERK signalling pathway in vivo and in vitro
por: Han, Ying‐Chao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e67447nlgj5nrh3uld7blnmd8u